Sort by
Refine Your Search
-
, allergenics, tissues, and cellular and gene therapies. Research Project: The candidates will contribute to projects focused on the development and validation of regulatory-relevant preclinical disease models
-
, pharmacovigilance, pharmacoepidemiology methods development). In general you will have opportunities to learn: Understanding of pharmacovigilance workflows; GenAI based algorithm and agent development for causality
-
. These efforts cover more than just medicines. Research Project: The aim of this research focuses on integrating FDA’s GenAI tool’s capabilities (through API calls) into the InfoViP platform while developing
-
to cross international boundaries and present a risk to U.S. livestock. The fellow will have the opportunity to contribute to the development of novel insecticides targeting arthropod pests of livestock
-
storage physiology, abiotic stress resilience, flavor and nutritional quality; and development of molecular tools, pest management and plant breeding strategies. Research Project: This appointment is
-
state-of-the-art cell engineering techniques to develop novel cellular models and hematopoietic differentiation methods for evaluating the safety and efficacy of advanced therapies. Additionally
-
to clinical trials. Later, you will learn FDA’s Elsa, a large language model-powered AI tool for use in extracting and summarizing information from application files and labeling and develop new generative and
-
of the proteins involved in post-transcriptional regulatory mechanisms during various stages of parasite development. This is a pioneering project that seeks to define the global post-transcriptional regulatory
-
, engineers, and researchers focused on developing medical clinical decision support systems utilizing extended reality technology. You will participate in various projects utilizing software engineering
-
of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following: Non-employee nature of the ORISE